4/19/2021 4:08:22 AM
Pfizer, BioNTech To Supply The European Union With 100 Mln Addl Doses Of COMIRNATY
4/12/2021 7:01:57 AM
Myovant, Pfizer: First Participant Dosed In Phase 3 SERENE Study
4/7/2021 6:47:08 AM
Pfizer Says FDA Extended Priority Review Period For NDA For Abrocitinib
4/1/2021 6:47:38 AM
Pfizer-BioNTech: COVID-19 Vaccine BNT162b2 Was 91.3% Effective, Measured 7 Days Through Up To 6 Months After Second Dose
3/31/2021 6:48:24 AM
Pfizer, BioNTech: BNT162b2 Showed 100% Efficacy, Robust Antibody Responses In Phase 3 Trial In Adolescents 12-15 Age
3/26/2021 8:29:30 AM
Astellas Receives Positive CHMP Opinion For XTANDI For Patients With Metastatic Hormone-Sensitive Prostate Cancer
3/25/2021 4:18:08 PM
Joint FDA Advisory Committee Votes On Application For Tanezumab For The Treatment Of Osteoarthritis Pain
3/25/2021 6:48:58 AM
Pfizer Says Real-World Evidence Supports Effectiveness Of First-line IBRANCE Combination Therapy
3/24/2021 6:39:10 AM
Myovant Sciences, Pfizer Announce Positive Data From Phase 3 LIBERTY Randomized Withdrawal Study